Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Werner Enterprises
WERN
$2.24B
| $1.8M | ﹤0.01% |
49,315
+11,443
| +30% | +$419K |
|
3102
CALL
Atlassian
TEAM
$38.3B
| $1.79M | ﹤0.01% |
14,900
-12,100
| -45% | -$1.47M |
|
|
SFIX
3103
Stitch Fix
SFIX
$556M
| $1.78M | ﹤0.01% |
69,510
-1,414
| -2% | -$32.8K |
|
3104
MBIA
MBI
$257M
| $1.78M | ﹤0.01% |
191,479
-15,707
| -8% | -$149K |
|
|
GTY
3105
Getty Realty Corp
GTY
$2.06B
| $1.78M | ﹤0.01% |
54,134
+1,193
| +2% | +$39.2K |
|
|
VRS
3106
DELISTED
Verso Corporation
VRS
| $1.78M | ﹤0.01% |
98,705
-7,313
| -7% | -$117K |
|
3107
PUT
Alcoa
AA
$13.1B
| $1.78M | ﹤0.01% |
82,600
-14,300
| -15% | -$296K |
|
3108
CALL
Medifast
MED
$143M
| $1.77M | ﹤0.01% |
16,200
+1,600
| +11% | +$155K |
|
|
CHNGU
3109
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $1.77M | ﹤0.01% |
29,576
-24,900
| -46% | -$1.28M |
|
|
CHX
3110
DELISTED
ChampionX
CHX
| $1.77M | ﹤0.01% |
52,406
-53,787
| -51% | -$1.46M |
|
|
SINA
3111
DELISTED
Sina Corp
SINA
| $1.77M | ﹤0.01% |
44,266
-14,244
| -24% | -$546K |
|
|
TCO
3112
DELISTED
Taubman Centers Inc.
TCO
| $1.76M | ﹤0.01% |
56,775
-26,168
| -32% | -$897K |
|
|
TPTX
3113
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.76M | ﹤0.01% |
28,295
+24,303
| +609% | +$1.16M |
|
3114
CALL
Analog Devices
ADI
$190B
| $1.76M | ﹤0.01% |
14,800
-27,700
| -65% | -$3.12M |
|
3115
CALL
iShares MSCI Mexico ETF
EWW
$1.99B
| $1.76M | ﹤0.01% |
39,000
-53,100
| -58% | -$2.36M |
|
|
GES
3116
CALL
DELISTED
Guess Inc
GES
| $1.75M | ﹤0.01% |
78,400
+57,300
| +272% | +$1.07M |
|
|
CVA
3117
DELISTED
Covanta Holding Corporation
CVA
| $1.75M | ﹤0.01% |
118,237
+20,275
| +21% | +$309K |
|
3118
PUT
Regions Financial
RF
$26.9B
| $1.75M | ﹤0.01% |
102,200
-5,000
| -5% | -$82.3K |
|
|
QEP
3119
DELISTED
QEP RESOURCES, INC.
QEP
| $1.75M | ﹤0.01% |
389,361
+134,529
| +53% | +$469K |
|
3120
PUT
Macerich
MAC
$6.86B
| $1.75M | ﹤0.01% |
64,900
+17,900
| +38% | +$492K |
|
3121
CALL
PVH
PVH
$4.03B
| $1.75M | ﹤0.01% |
16,600
-52,900
| -76% | -$5.05M |
|
3122
PUT
T. Rowe Price
TROW
$24.3B
| $1.74M | ﹤0.01% |
14,300
+5,400
| +61% | +$638K |
|
3123
PUT
Ambarella
AMBA
$3.81B
| $1.74M | ﹤0.01% |
28,700
+17,200
| +150% | +$953K |
|
3124
Hubbell
HUBB
$27.3B
| $1.74M | ﹤0.01% |
11,739
-6,466
| -36% | -$921K |
|
3125
Stride
LRN
$3.39B
| $1.73M | ﹤0.01% |
85,053
+43,994
| +107% | +$940K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.